Felix Mahfoud

[Circulation @CircAHA]

Meta-analysis of renal denervation in hypertension @DLBhattMD @Kandzari @LucasLauder @ajaykirtane @DavorVuk @FelixMahfoud https://t.co/h1apTwfC3d

[Felix Mahfoud @FelixMahfoud]

@InariMedical @jaygirimd @JonnyMoriarty @thiele_holger @CatalinPToma An important trial that is set to significantly advance our understanding of managing high-risk pulmonary embolism

[Inari, now part of Stryker @InariMedical]

@jaygirimd @JonnyMoriarty Thank you to the entire #PERSEVERE steering committee for your dedication to advancing the standard of care for pulmonary embolism patients @jaygirimd @JonnyMoriarty Stefano Barco, Lukas Hobohm, @FelixMahfoud, Stephan Rosenkranz, Andrew Sharp, @thiele_holger, @CatalinPToma

[Felix Mahfoud @FelixMahfoud]

https://t.co/vZYzZTdkS4

[Felix Mahfoud @FelixMahfoud]

The 2024 ESC GLs on Hypertension are here! Key updates: New BP category: "Elevated BP" (120-139/70-89 mmHg) - Target systolic BP: 120-129 mmHg (if tolerated)-Focus on CVD outcomes over BP reduction alone-Personalized treatment #ESCCongress2024 #hypertension

[Felix Mahfoud @FelixMahfoud]

@rwyeh @EricSecemskyMD @SmithBIDMC Congrats Eric - well deserved!

[Inari, now part of Stryker @InariMedical]

We are proud to recognize PEERLESS II as our 3rd #RCT in #VTE. Across #PEERLESS & #PEERLESSII, Inari is now set to enroll over 1700 #PE RCT patients.

Thank you to the PEERLESS II Global PIs for your partnership & dedication to generating high quality clinical evidence: @jaygirimd, @FMaeWestMD, @FelixMahfoud, & Prof Bernhard Gebauer.

[Felix Mahfoud @FelixMahfoud]

@aerztezeitung @DGK_org @Saar_Uni Important information for all patients with #hypertension. High amount of hidden sodium in effervescent-tablet dietary supplements and OTC drugs. Patients at risk should be advised to limit effervescent tablets. @BMJ_Open https://t.co/xAcmNudqWJ @Herzmedizin_de

[Ärzte Zeitung @aerztezeitung]

Brausetabletten enthalten große Mengen an #Natrium und könnten daher #Hypertonie-Kranke gefährden, warnen Kardiologen @DGK_org. Sie fordern eine Kennzeichnungspflicht auf Verpackungen. Zitiert wird auch @FelixMahfoud von der @Saar_Uni. #Kardiologie
https://t.co/Np9j0yoMke

[Felix Mahfoud @FelixMahfoud]

@UniBasel @mertz_kirsten Very happy and proud to start @UniSpitalBasel and @UniBasel next year June! Exciting times.

[Universität Basel @UniBasel]

Der Universitätsrat hat @mertz_kirsten zur Professorin für Allgemeine Pathologie sowie @FelixMahfoud zum Professor für Kardiologie gewählt.

👉 https://t.co/7IQxXlCATD

[Amr Abdin @AmrAbdin10]

💡Liver function🧪 associated with HF🏥+CV☠️ in #HFpEF.
👉Tx benefits of #empagliflozin were not affected by baseline values of liver parameters. doi:10.1002/ejhf.2922
@Saar_Uni @LucasLauder @FelixMahfoud @JavedButler1 @Filippatos @HanCardiomd #ukskardio @GiuseppeGalati_

[Dr Anastasia Mihailidou FAHA FCSANZ FESC @AnastasiaSMihai]

Congratulations @AndrewJSauer 👏👏

You missed @escardio #ESCCongress ⭐️ session @FelixMahfoud & I Chaired:

Meet the Experts: #Hypertension in #HeartFailure

2 case presentations #HFpEF & #HFrEF where #MRAs & #GDMT were🔦 & great discussion with #MRA legend @FaiezZANNADD & other ⭐️ Faculty

[Felix Mahfoud @FelixMahfoud]

@AnastasiaSMihai @escardio @DrMarthaGulati @mmamas1973 @Hragy @HanCardiomd @atunuguntla1 @AnnaKateBarton @Pooh_Velagapudi @vass_vassiliou @SilCastelletti @nicolasrennamd Very nice seeing you all in a crowded hypertension session at #ESCCongress. More to come!

[Felix Mahfoud @FelixMahfoud]

@SamuelSossalla @DGK_org @dzhk_germany @chris_sohns @dirkwestermann @bwu74 @uni_regensburg @PabelSteffen @BengelPhilipp @DrMichaelWester @SarahRipfel @ffochler13 Congratulations on your well-deserved success, Samuel! Wishing the very best at your new place.

[Felix Mahfoud @FelixMahfoud]

@SamuelSossalla @ReischauerS @CPI_ExStra @GiessenPh @dzhk_germany @YoungDgk @dirkwestermann @UKGM_Presse @chris_sohns @ViclouiseJ @BengelPhilipp @PabelSteffen @LauraZelarayan2 @BiomarkerJLU @schogerandspice @ChristianT25500 Congratulations

[EuroIntervention @EuroInterventio]

🔉The new Impact Factor of EuroIntervention is 6.2.
This achievement places the journal once again in the top quartile among cardiovascular publications and solidifies our position as the second-ranked subspecialty journal in interventional cardiology. Thank you to all!

[Felix Mahfoud @FelixMahfoud]

@InariMedical @jaygirimd @Thomas_TuMD @FMaeWestMD Important trial announced today with up to 1200 pts randomized. Look forward to getting it started!

[Nature Reviews Cardiology @NatRevCardiol]

In our latest Review, @FelixMahfoud et al. discuss interventional therapies for pulmonary embolism. Check it out here: https://t.co/sBDfnZno1q

[Davide Capodanno @DFCapodanno]

This statement of the @escardio Council on Hypertension and the #EAPCI reviews the evidence on renal denervation and provides consensus statements for patient selection, centre requirements, procedural aspects, and considerations for trial design.
https://t.co/4EiXl61aTq